Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Hilmi Apak (Hematologist/oncologist, Pediatric hematologist, Pediatric hematologist/oncologist)– Best Costs, Reviews – Book Your Consultation
Prof. Dr. Hilmi Apak is a board‑certified pediatric hematologist‑oncologist with over 25 years of experience. He practices at Biruni University Hospital in Istanbul, specializing in blood and cancer disorders in children.
- Title: Prof. Dr.
- Specialty: Pediatric Hematology & Oncology
- Years of Experience: 25+
- Main Focus: Childhood leukemia, lymphomas, bone marrow transplantation, benign blood disorders, CAR‑T therapy
Educational Background
- MD: Istanbul University Faculty of Medicine (1980–1986)
- Pediatrics Residency: Istanbul University Cerrahpaşa (1989–1994)
- Subspecialty Training: Pediatric Hematology & Oncology at Istanbul University (1994–today)
Professional Experience
- Current: Pediatric Hematology‑Oncology Specialist, Biruni University Hospital, Istanbul (since 2023)
- Head of Division: Pediatric Hematology‑Oncology, Istanbul University‑Cerrahpaşa (2002–2024)
- Head of Pediatrics Department: Istanbul University (since 2007)
- Consultant: Pediatric Hematology‑Oncology at Liv Hospital (2013–2021)
- Academic Board Member: Department of Pediatrics, Istanbul University (since 2002)
Academic Contributions
- Served as assistant editor for Turkish Pediatrics Archives journal
- Published over 75 international peer‑reviewed articles in hematology and oncology
- Presented original data on chronic pediatric ITP and Hodgkin lymphoma at national and international meetings
- Mentored numerous residents and fellows in pediatric hematology‑oncology
Areas of Expertise
Prof. Dr. Apak treats a broad range of pediatric blood and cancer conditions:
- Leukemia: Diagnosis and chemotherapy protocols for acute leukemias
- Lymphomas: Treatment of Hodgkin and non‑Hodgkin lymphomas, including immunotherapy
- Bone Marrow Transplant: Performing autologous, allogeneic, haploidentical stem cell transplants
- Chronic ITP: Managing low platelet counts with medical therapy and with splenectomy where necessary
- Rare Disorders: Treating mastocytosis, hemoglobinopathies, Glanzmann thrombasthenia and related conditions
- CAR‑T Therapy: Advanced cellular therapy for relapsed blood cancers
Publications and Research
Prof. Dr. Apak has contributed landmark studies to pediatric hematology-oncology:
- Experience with pediatric chronic immune thrombocytopenia over 30 years: confirmed that one-third of cases remit spontaneously, with splenectomy effective for severe cases.
- Study on EBV LMP‑1 staining in childhood Hodgkin lymphoma: assessed prognostic value of viral markers in survival outcomes.
- Retrospective review of febrile neutropenia in children with ALL: supported improvements in supportive care protocols.
Patient Care Philosophy
- Emphasizes compassionate, family‑centered communication, providing clear explanations to parents
- Supports informed decision‑making through education on treatments and side effects
- Welcomes international patients with structured online consultations and cultural sensitivity
- Strives for optimal clinical outcomes with minimal stress for children and families
Professional Affiliations
- Professor and former Head of Pediatric Hematology‑Oncology at Istanbul University‑Cerrahpaşa
- Member of Turkish Pediatric Oncology Society, Turkish Pediatric Hematology Society, Turkish Pediatric Association
- Served as assistant editor of Turkish Pediatrics Archives journal
- Licensed pediatric hematologist‑oncologist in Turkey
FAQs
- Is Dr. Hilmi Apak board‑certified?
- Yes, he is board‑certified in pediatrics and pediatric hematology‑oncology, with over 25 years of practice.
- What treatments does he perform?
- He provides leukemia and lymphoma chemotherapy, bone marrow transplants, CAR‑T therapy, and treats benign blood disorders like ITP and thalassemia.
- Does he treat international patients?
- Yes, he manages international referrals with online pre‑consultations and coordination of treatment plans.
- How long is the typical hospital stay?
- Hospital stays vary: chemotherapy may require a few days, while bone marrow transplant care often spans several weeks.
- What languages does he speak?
- He speaks Turkish fluently and communicates effectively in English.
- Does he publish research?
- Yes, he has authored over 75 international publications and remains active in clinical research.
- Where does he practice?
- He practices at Biruni University Hospital in Istanbul and is affiliated with Istanbul University‑Cerrahpaşa.
Patient reviews
Patient reviews
